Trump administration lets compounding pharmacies make six popular peptides without FDA approval

Summary

The U.S. government will no longer penalize American companies for making six popular peptides, including BPC-157 and TB-500, and will not act against compounding pharmacies that make them. Under the new policy, the Department of Health and Human Services will let small compounding pharmacies make six peptides that the Food and Drug Administration has not approved, and compounded combinations of these peptides can now be dispensed by certain pharmacies. NPR reported that this may not be enough to meet demand.

Timeline

1. MarketWatch

   28 Oct 2026, 16:57 UTCSource ↗

   MarketWatch reports that the U.S. government will no longer penalize American companies for making six popular peptides and won't take action against compounding pharmacies that make wellness products such as BPC-157 and TB-500.

2. Scientific American

   28 Oct 2026, 18:45 UTCSource ↗

   Scientific American reports that HHS Secretary RFK Jr. loosened restrictions on six popular peptides, bypassing the FDA, and that under the new policy certain pharmacies can now dispense compounded combinations of these unproven peptides.

3. NPR

   28 Oct 2026, 22:26 UTCSource ↗

   NPR reports that the Department of Health and Human Services will let small compounding pharmacies make six peptides that the FDA has not approved, and that this may not be enough to meet demand.